Temperature sensitivity of phospho-Ser473-PKB/AKT

Biochemical and Biophysical Research Communications

Volumn 375, Issue 3, 2008, Pages 399-404

  Oehler Jänne, Christoph ^a   Bueren, André O von ^b   Vuong, Van ^a   Hollenstein, Andreas ^a   Grotzer, Michael A ^b   Pruschy, Martin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Ionizing radiation; p Ser473 PKB Akt; PDK2; Phosphorylation; PP2A; Stability; Temperature sensitivity

Indexed keywords

PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SERINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IRRADIATION; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; STRESS; TEMPERATURE; TEMPERATURE SENSITIVITY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; DOWN-REGULATION; HEAT; HUMANS; MICE; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE;

MURINAE;

EID: 50849103001     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.035     Document Type: Article

References (41)

1. Denley A., Kang S., Karst U., and Vogt P.K. Oncogenic signaling of class I PI3K isoforms. Oncogene 27 (2008) 2561-2574
2. Kang S., Denley A., Vanhaesebroeck B., and Vogt P.K. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 103 (2006) 1289-1294
3. Meng Q., Xia C., Fang J., Rojanasakul Y., and Jiang B.H. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal. 18 (2006) 2262-2271
4. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., and Velculescu V.E. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
5. Moore S.M., Rintoul R.C., Walker T.R., Chilvers E.R., Haslett C., and Sethi T. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res. 58 (1998) 5239-5247
6. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., and Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21 (1999) 99-102
7. Muss H.B., Thor A.D., Berry D.A., Kute T., Liu E.T., Koerner F., Cirrincione C.T., Budman D.R., Wood W.C., Barcos M., et al. C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med. 330 (1994) 1260-1266
8. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H., Fujii Y., Eck M.J., Sellers W.R., Johnson B.E., and Meyerson M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
9. Zhou B.P., Liao Y., Xia W., Spohn B., Lee M.H., and Hung M.C. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3 (2001) 245-252
10. Jimenez C., Jones D.R., Rodriguez-Viciana P., Gonzalez-Garcia A., Leonardo E., Wennstrom S., von Kobbe C., Toran J.L., Calvo R.B.L.V., Copin S.G., Albar J.P., Gaspar M.L., Diez E., Marcos M.A., Downward J., Martinez A.C., Merida I., and Carrera A.C. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 17 (1998) 743-753
11. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
12. Lin J., Adam R.M., Santiestevan E., and Freeman M.R. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res. 59 (1999) 2891-2897
13. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
14. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., and Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
15. Mayo L.D., and Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98 (2001) 11598-11603
16. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96 (1999) 857-868
17. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
18. Rodemann H.P., Dittmann K., and Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int. J. Radiat. Biol. 83 (2007) 781-791
19. Bussink J., van der Kogel A.J., and Kaanders J.H. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol. 9 (2008) 288-296
20. Toulany M., Baumann M., and Rodemann H.P. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol. Cancer Res. 5 (2007) 863-872
21. Dent P., Yacoub A., Contessa J., Caron R., Amorino G., Valerie K., Hagan M.P., Grant S., and Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat. Res. 159 (2003) 283-300
22. Wymann M.P., and Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436 (1998) 127-150
23. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., and Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15 (1996) 6541-6551
24. Carpten J.D., Faber A.L., Horn C., Donoho G.P., Briggs S.L., Robbins C.M., Hostetter G., Boguslawski S., Moses T.Y., Savage S., Uhlik M., Lin A., Du J., Qian Y.W., Zeckner D.J., Tucker-Kellogg G., Touchman J., Patel K., Mousses S., Bittner M., Schevitz R., Lai M.H., Blanchard K.L., and Thomas J.E. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448 (2007) 439-444
25. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 Pt 3 (2000) 561-576
26. Martelli A.M., Cocco L., Capitani S., Miscia S., Papa S., and Manzoli F.A. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. Eur. J. Histochem. 51 Suppl 1 (2007) 125-131
27. Xu G., Zhang W., Bertram P., Zheng X.F., and McLeod H. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors. Int. J. Oncol. 24 (2004) 893-900
28. Available from: .
29. Baker A.F., Dragovich T., Ihle N.T., Williams R., Fenoglio-Preiser C., and Powis G. Stability of phosphoprotein as a biological marker of tumor signaling. Clin. Cancer Res. 11 (2005) 4338-4340
30. Takai A., Ohno Y., Yasumoto T., and Mieskes G. Estimation of the rate constants associated with the inhibitory effect of okadaic acid on type 2A protein phosphatase by time-course analysis. Biochem. J. 287 Pt 1 (1992) 101-106
31. Andrabi S., Gjoerup O.V., Kean J.A., Roberts T.M., and Schaffhausen B. Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc. Natl. Acad. Sci. USA 104 (2007) 19011-19016
32. Cai D., McCarron R.M., Yu E.Z., Li Y., and Hallenbeck J. Akt phosphorylation and kinase activity are down-regulated during hibernation in the 13-lined ground squirrel. Brain Res. 1014 (2004) 14-21
33. Tomimatsu T., Fukuda H., Endo M., Watanabe N., Mu J., Kohzuki M., Fujii E., Kanzaki T., and Murata Y. Effects of hypothermia on neonatal hypoxic-ischemic brain injury in the rat: phosphorylation of Akt, activation of caspase-3-like protease. Neurosci. Lett. 312 (2001) 21-24
34. Torsoni M.A., Carvalheira J.B., Pereira-Da-Silva M., de Carvalho-Filho M.A., Saad M.J., and Velloso L.A. Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E216-E223
35. Maher P.A. Nerve growth factor induces protein-tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 85 (1988) 6788-6791
36. Tsuruta H., Mikami B., and Aizono Y. Crystal structure of cold-active protein-tyrosine phosphatase from a psychrophile, Shewanella sp. J. Biochem. (Tokyo) 137 (2005) 69-77
37. Monroy A.F., Labbe E., and Dhindsa R.S. Low temperature perception in plants: effects of cold on protein phosphorylation in cell-free extracts. FEBS Lett. 410 (1997) 206-209
38. Dong L.Q., and Liu F. PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E187-E196
39. Sato S., Fujita N., and Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. USA 97 (2000) 10832-10837
40. Hresko R.C., and Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 40406-40416
41. Reiling J.H., and Sabatini D.M. Stress and mTORture signaling. Oncogene 25 (2006) 6373-6383